Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Boost with ChAd63 and MVA ME-TRAP for Malaria
NCT03707353Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Oct 2018
- Primary completion
- Jun 2019
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ChAd63 ME-TRAP, MVA ME-TRAP in malaria, sponsored by University of Oxford. Started Oct 2018; status: completed.
02
Drugs
ChAd63 ME-TRAPMVA ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03707353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03707353.